Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.

The emergence of carbapenemases in Enterobacteriaceae has raised global concern among the scientific, medical and public health communities. Both the CDC and the WHO consider carbapenem-resistant Enterobacteriaceae (CRE) to constitute a significant threat that necessitates immediate action. In this article, we review the challenges faced by laboratory workers, infection prevention specialists and clinicians who are confronted with this emerging infection control issue.

[1]  D. Raoult,et al.  New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  Y. Carmeli,et al.  An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Paterson,et al.  The spread and acquisition of NDM-1: a multifactorial problem , 2014, Expert review of anti-infective therapy.

[4]  J. Takkinen,et al.  Annual Epidemiological Report, 2013. Reporting on 2011 surveillance data and 2012 epidemic intelligence data. , 2014 .

[5]  P. Vanhems,et al.  Health care workers travelling abroad: investigation of carbapenemase-producing enterobacteriaceae infection possibly acquired overseas. , 2014, American journal of infection control.

[6]  Arti Kapi.  The evolving threat of antimicrobial resistance: Options for action , 2014 .

[7]  P. Gastmeier,et al.  Klebsiella spp. in endoscopy-associated infections: we may only be seeing the tip of the iceberg , 2014, Infection.

[8]  Michael Y. Lin,et al.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Mathers,et al.  Admission Surveillance for Carbapenamase-Producing Enterobacteriaceae at a Long-Term Acute Care Hospital , 2013, Infection Control & Hospital Epidemiology.

[10]  K. Carroll,et al.  The Challenges of Carbapenemase-Producing Enterobacteriaceae and Infection Prevention: Protecting Patients in the Chaos , 2013, Infection Control & Hospital Epidemiology.

[11]  R. Humphries,et al.  New Delhi Metallo-β-Lactamase–producing Enterobacteriaceae, United States , 2013, Emerging infectious diseases.

[12]  Y. Carmeli,et al.  Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  P. Tambyah,et al.  The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Y. Carmeli,et al.  Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  R. Bonomo,et al.  “Stormy waters ahead”: global emergence of carbapenemases , 2013, Front. Microbiol..

[16]  P. Nordmann,et al.  Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems. , 2013, Diagnostic microbiology and infectious disease.

[17]  J. Hrabák,et al.  Matrix-Assisted Laser Desorption Ionization–Time of Flight (MALDI-TOF) Mass Spectrometry for Detection of Antibiotic Resistance Mechanisms: from Research to Routine Diagnosis , 2013, Clinical Microbiology Reviews.

[18]  Michael Y. Lin,et al.  Anatomic Sites of Patent Colonization and Environmental Contamination with Klebsiella pneumoniae Carbapenemase—Producing Enterobacteriaceae at Long-Term Acute Care Hospitals , 2013, Infection Control & Hospital Epidemiology.

[19]  K. Carroll,et al.  Infection Prevention Considerations Related to New Delhi Metallo-β-Lactamase Enterobacteriaceae A Case Report , 2013, Infection Control & Hospital Epidemiology.

[20]  Paul D. Cotter,et al.  Nucleic acid-based approaches to investigate microbial-related cheese quality defects , 2012, Front. Microbio..

[21]  J. Myers,et al.  An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Matthaios Papadimitriou-Olivgeris,et al.  Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. , 2012, The Journal of antimicrobial chemotherapy.

[23]  Michael Y. Lin,et al.  Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study , 2012, Infection Control & Hospital Epidemiology.

[24]  V. B. D. De Rochars,et al.  Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions , 2012, Infection Control & Hospital Epidemiology.

[25]  J. Pitout,et al.  The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. , 2012, The Journal of antimicrobial chemotherapy.

[26]  Evan S Snitkin,et al.  Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing , 2012, Science Translational Medicine.

[27]  T. Perl,et al.  A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings , 2012, Current opinion in infectious diseases.

[28]  A. Hatzakis,et al.  Transmission Dynamics of Carbapenemase-Producing Klebsiella Pneumoniae and Anticipated Impact of Infection Control Strategies in a Surgical Unit , 2012, PloS one.

[29]  J. Perry,et al.  Comparison of Four Chromogenic Culture Media for Carbapenemase-Producing Enterobacteriaceae , 2012, Journal of Clinical Microbiology.

[30]  D. Landman,et al.  Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. , 2012, The Journal of antimicrobial chemotherapy.

[31]  D. Livermore.  Current Epidemiology and Growing Resistance of Gram-Negative Pathogens , 2012, The Korean journal of internal medicine.

[32]  K. Mangold,et al.  Rectal Screening for Klebsiella pneumoniae Carbapenemases: Comparison of Real-Time PCR and Culture Using Two Selective Screening Agar Plates , 2012, Journal of Clinical Microbiology.

[33]  Y. Carmeli,et al.  Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  C. Urban,et al.  Klebsiella pneumoniae Carbapenemases in Enterobacteriaceae: History, Evolution, and Microbiology Concerns , 2012, Pharmacotherapy.

[35]  V. Miriagou,et al.  Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[36]  P. Nordmann,et al.  Carbapenemase-producing Enterobacteriaceae: a call for action! , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  S. Shea,et al.  Adverse Metabolic Consequences in Humans of Prolonged Sleep Restriction Combined with Circadian Disruption , 2012, Science Translational Medicine.

[38]  G. Zambardi,et al.  Comparative Evaluation of a Prototype Chromogenic Medium (ChromID CARBA) for Detecting Carbapenemase-Producing Enterobacteriaceae in Surveillance Rectal Swabs , 2012, Journal of Clinical Microbiology.

[39]  P. Nordmann,et al.  Detection of Carbapenemase Producers in Enterobacteriaceae by Use of a Novel Screening Medium , 2012, Journal of Clinical Microbiology.

[40]  K. Riesenberg,et al.  A Randomized, Double-Blind, Placebo-Controlled Trial of Selective Digestive Decontamination Using Oral Gentamicin and Oral Polymyxin E for Eradication of Carbapenem-Resistant Klebsiella pneumoniae Carriage , 2012, Infection Control & Hospital Epidemiology.

[41]  M. Toleman,et al.  The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. , 2012, The Journal of antimicrobial chemotherapy.

[42]  D. Livermore,et al.  The emerging NDM carbapenemases. , 2011, Trends in microbiology.

[43]  N. Woodford,et al.  Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. , 2011, The Journal of antimicrobial chemotherapy.

[44]  R. Weinstein,et al.  Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  P. Nordmann,et al.  Long-term carriage of NDM-1-producing Escherichia coli. , 2011, The Journal of antimicrobial chemotherapy.

[46]  J. Bartlett,et al.  A call to arms: the imperative for antimicrobial stewardship. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  S. Zimmermann,et al.  Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry To Detect Carbapenem Resistance within 1 to 2.5 Hours , 2011, Journal of Clinical Microbiology.

[48]  V. Jarlier,et al.  Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[49]  D. Livermore,et al.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.

[50]  D. Morgan,et al.  Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria , 2011, Southern medical journal.

[51]  G. Cornaglia,et al.  New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[52]  T. Walsh.  Emerging carbapenemases: a global perspective. , 2010, International journal of antimicrobial agents.

[53]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[54]  M. Adams,et al.  Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. , 2010, The Journal of antimicrobial chemotherapy.

[55]  Iraida E. Robledo,et al.  Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Puerto Rico Associated with a Novel Carbapenemase Variant , 2010, Infection Control & Hospital Epidemiology.

[56]  A. Dalpke,et al.  First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[57]  Michael Y. Lin,et al.  Successful Control of an Outbreak of Klebsiella pneumoniae Carbapenemase—Producing K. pneumoniae at a Long-Term Acute Care Hospital , 2010, Infection Control & Hospital Epidemiology.

[58]  A. Armaganidis,et al.  An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  M. Synnestvedt,et al.  Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae , 2009, Infection Control & Hospital Epidemiology.

[60]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[61]  Gopi Patel,et al.  Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.

[62]  Yehuda Carmeli,et al.  Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.

[63]  Robert A. Weinstein,et al.  Contamination, Disinfection, and Cross-Colonization: Are Hospital Surfaces Reservoirs for Nosocomial Infection? , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.